Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: | Xofluza |
Active Ingredient: | Baloxavir marboxil 20mg |
Dosage Form: | Film coated tablet |
New Zealand Sponsor: | Roche Products (NZ) Limited |
Manufacturer: | Shionogi Pharma Co. Limited, Settsu, Japan |
Product: | Xofluza |
Active Ingredient: | Baloxavir marboxil 40mg |
Dosage Form: | Film coated tablet |
New Zealand Sponsor: | Roche Products (NZ) Limited |
Manufacturer: | Shionogi Pharma Co. Limited, Settsu, Japan |
Dated this 4th day of October 2021.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).